Document is current
Any future updates will be listed below
-
Authors
Bellgardt, Martin https://orcid.org/0000-0001-9447-0019
Georgevici, Adrian Iustin
Klutzny, Mitja
Drees, Dominik
Meiser, Andreas
Gude, Philipp
Vogelsang, Heike
Weber, Thomas Peter
Herzog-Niescery, Jennifer
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03860129 at ClinicalTrials.govDocuments that mention this clinical trial
Use of MIRUS™ for MAC-driven application of isoflurane, sevoflurane, and desflurane in postoperative ICU patients: a randomized controlled trial
https://doi.org/10.1186/s13613-019-0594-8
Negative drift of sedation depth in critically ill patients receiving constant minimum alveolar concentration of isoflurane, sevoflurane, or desflurane: a randomized controlled trial
https://doi.org/10.1186/s13054-021-03556-y
- License Information
-
More Information
Article History
Received: 30 May 2019
Accepted: 5 October 2019
First Online: 16 October 2019
Ethics approval and consent to participate
: This prospective study was performed in a German University Hospital between February 2016 and Mai 2017. It was approved by the appropriate Institutional Review Board (Ethikkommission der Ruhr-Universität Bochum, 4780-13) and registered at the Clinical Trials Registry (ref.: NCT03860129). Written informed consent was obtained from all patients prior to their inclusion in this study. Measurements complied with the ethical standards of the Declaration of Helsinki.
: Not applicable.
: MB, AM, and JH-N received speakers’ honoraria from Pall Medical, Dreieich, Germany, the former owner of the MIRUS System in 2017 (1200 € each). The other authors declare that they have no competing interests.
